Literature DB >> 28535646

[The research advances in the relationship between visfatin and cancer].

W Y Tian1, Y M Wang1, Y F Zhang1, F X Xue1.   

Abstract

Visfatin is a cytokine secreted by visceral adipose tissue, which plays an important role in obesity, diabetes, insulin resistance, atherosclerosis and polycystic ovarian syndrome. Additionally, visfatin is also involved in the metabolic syndrome-associated malignancies such as breast, colon, gastric and endometrial cancers. Visfatin inhibitor might be a potential antitumor therapeutic strategy for inhibiting the growth of many cancers.

Entities:  

Keywords:  Biomarker; Metabolic syndrome; Neoplasms; Visfatin; Visfatin inhibitor

Mesh:

Substances:

Year:  2017        PMID: 28535646     DOI: 10.3760/cma.j.issn.0253-3766.2017.05.001

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  1 in total

1.  Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

Authors:  Aneta Cymbaluk-Płoska; Anita Chudecka-Głaz; Ewa Pius-Sadowska; Agnieszka Sompolska-Rzechuła; Bogusław Machaliński; Janusz Menkiszak
Journal:  Biomed Res Int       Date:  2018-01-04       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.